Generative Data Intelligence

Tag: WELL

How to Play Crypto Unicorns NFT Game | Philippines Guide

Here is the BitPinas guide to Crypto Unicorns, a new NFT play-to-earn game. For Philippine players, find out how to play the game, as well as its numerous gameplay mechanics.

The post How to Play Crypto Unicorns NFT Game | Philippines Guide appeared first on BitPinas.

What is now Trading in RFR Cross Currency Swaps?

Cross Currency swap trading has transition quickly to USD SOFR and away from USD LIBOR in 2022. All of the currency pairs we look at show evidence of a transition to USD SOFR. Some markets are now trading RFR vs RFR Cross Currency Swaps. Most of the other markets now trade Term domestic rates vs […]

ConsenSys Acquires MyCrypto to Strengthen MetaMask

ConsenSys also emphasized the digital wallets’ experience in weathering fluctuations in market cycles as well as their collaborations to persistently to educate the Ethereum community on security best practices.

The post ConsenSys Acquires MyCrypto to Strengthen MetaMask appeared first on BitPinas.

CoinTracker lands unicorn status with $100m Series A round

Users collectively track over $50 billion in crypto assets on CoinTracker.

Hacker Group ‘Moses Staff’ Using New StrifeWater RAT in Ransomware Attacks

A politically motivated hacker group tied to a series of espionage and sabotage attacks on Israeli entities in 2021 incorporated a previously undocumented remote access trojan (RAT) that masquerades as the Windows Calculator app as part of a conscious effort to stay under the radar. Cybersecurity company Cybereason, which has been tracking the operations of the Iranian actor known as Moses Staff

Crypto’s 69 most interesting charts from 2021

As most of us were enjoying some R&R over Christmas break, Coinbase Cloud protocol specialist Elias Simos was scouring the web for the...

Mitsubishi Shipbuilding Concludes Agreement on Construction of World’s First Demonstration Test Ship for Liquefied CO2 Transportation

TOKYO, Feb 2, 2022 - (JCN Newswire) - Mitsubishi Shipbuilding Co., Ltd., a Yokohama-based member of Mitsubishi Heavy Industries (MHI) Group, has concluded a contract with Sanyu Kisen Co., Ltd., a Kobe-based enterprise principally engaged in management of ships navigation in Japanese as well as foreign waters, calling for the construction of a demonstration test ship to transport liquefied carbon dioxide (LCO2) in conjunction with initiatives of the New Energy and Industrial Technology Development Organization (NEDO) in "CCUS R&D and Demonstration Related Project / Large-scale CCUS Demonstration in Tomakomai / Demonstration Project on CO2 Transportation / R&D and Demonstration Project for CO2 Marine Transportation" (the demonstration projects). Construction will get underway at the Enoura Plant of MHI's Shimonoseki Shipyard & Machinery Works, with completion and delivery scheduled for the second half of the fiscal 2023.

Conceptual image of the LCO2 demonstration test ship

The Engineering Advancement Association of Japan (ENAA), one of the entities performing business relating to the demonstration projects, will charter the ship from Sanyu Kisen, the subcontractor, and operate it for the project purposes. Under consignment from ENAA, three additional project partners - Kawasaki Kisen Kaisha, Ltd. ("K" LINE), Nippon Gas Line Co., Ltd., and Ochanomizu University - will accelerate R&D of the LCO2 transportation technology and contribute to cost reduction of CCUS technology and safe, long-distance and large-scale transportation of LCO2.

Although ships to carry LCO2 used in the food industry have previously been constructed and operated in Europe and Japan, the ship to be newly constructed is expected to be the world's first LCO2 carrier intended specifically for CCUS. Mitsubishi Shipbuilding will be in charge of all aspects from the ship design through construction, including the cargo containment system, applying its gas handling technologies and expertise cultivated through the construction of liquefied gas carriers (both LPG and LNG types).

CCUS is garnering attention today as an effective means of achieving a carbon-neutral society. Because CO2 emissions sites are often located distant from the sites selected for carbon utilization or storage, demand is expected to increase for LCO2 carriers which can transport their cargo safely and economically. Through the experience to be gained by constructing the world's first LCO2 carrier built specifically for CCUS, MHI Group will strengthen its current strategic business focused on the energy transition. The Company will also continue its dedication to developing and providing the technologies relating to LCO2 carriers necessary for CCUS value chain building, to contribute to CO2 ecosystem development.

Mitsubishi Shipbuilding, under its "MARINE FUTURE STREAM" growth strategy, has set two overarching targets: decarbonization through innovative technologies in maritime industry such as use of renewable energies and carbon recycling, and effective use of ocean spaces through autonomous operation and electrification. To achieve those goals, the company aims to pursue and realize diverse innovations applicable to the industry. The ongoing development of LCO2 carriers and active quest for commercial viability in this area are part of those initiatives, with the company's ultimate goal set on realizing decarbonization as a marine system integrator.

About MHI Group

Mitsubishi Heavy Industries (MHI) Group is one of the world's leading industrial groups, spanning energy, logistics & infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on www.spectra.mhi.com.


Copyright 2022 JCN Newswire. All rights reserved. www.jcnnewswire.comMitsubishi Shipbuilding Co., Ltd., a Yokohama-based member of Mitsubishi Heavy Industries (MHI) Group, has concluded a contract with Sanyu Kisen Co., Ltd., a Kobe-based enterprise principally engaged in management of ships navigation in Japanese as well as foreign waters.

How To Amplify Your Holdings with Ravencoin Loans?

Nevertheless crypto mainstream in the latest years, many things are still relatively new. On CoinRabbit we try to provide some assets with a better crypto adoption. This is the case of Ravencoin, which with other great assets in the cryptocurrency sphere, has a direct impact on the development of the crypto world. You can easily ... Read more

The post How To Amplify Your Holdings with Ravencoin Loans? first appeared on Blog.

LoL: LCS Power Rankings After Lock In

The preseason tournament for LCS 2022 has ended, and gave us a plethora of surprises. January 31 marks the end…

The post LoL: LCS Power Rankings After Lock In appeared first on Esports News Network | ESTNN.

Amber Group Acquires Japan-based DeCurret Trading Firm


Global digital assets platform, Amber Group has taken up ownership of Japan-based cryptocurrency trading platform, DeCurret in a concluded transaction with no monetary terms declared. (Read More)

VanEck Floats its Multi-Coin Crypto ETN in Europe


VanEck, one of the foremost issuers of cryptocurrency-focused investment products, has announced the launch of its multi-coin cryptocurrency fund in Europe. (Read More)

Shonan Kamakura Advanced Medical Center Begins Treatment with Hitachi’s First Dedicated Compact Proton Therapy System

TOKYO, Feb 2, 2022 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) has announced that "Shonan Kamakura Advanced Medical Center" at Shonan Kamakura General Hospital of Tokushukai Medical Group, where Hitachi's compact proton therapy system (hereafter, "the system") has been installed, has commenced treatment with the system on 31 January 2022. This is the first order for Hitachi's dedicated compact proton therapy system.

Proton Therapy System

Shonan Kamakura Advanced Medical Center is a medical facility providing comprehensive cancer treatment, including advanced radiotherapy, built adjacent to the site of Shonan Kamakura General Hospital by Tokushukai Group Medical Corporation, which operates approximately 400 medical facilities and nursing homes throughout Japan. Until now, there have been no proton therapy facilities in Kanagawa Prefecture, where the center is located, but the compact proton therapy system, with its reduced footprint, makes it possible to install a proton therapy facility on a limited site close to the city center.

Features of the installed system

In response to the growing worldwide demand for smaller proton therapy systems, Hitachi has developed the proton therapy system, which is specifically designed for a single treatment room. The system is a compact proton therapy system which, by optimizing the layout of the machine, reduces the installation area to about 70% of that of conventional solutions, making it possible to install the system on a limited site in an urban area and reducing the cost and time involved in its installation. It is equipped with advanced technologies such as spot scanning irradiation technology, which allows the proton beam to be delivered according to the shape of the cancer, a 360degree rotating gantry with cone-beam CT(1) for high-precision positioning, and Real-time image Gated Proton Therapy (RGPT)(2), making it both compact and highly functional.

Hitachi is committed to accelerating the global development of particle therapy system and contributing to cancer treatment around the world, as well as to further expanding its healthcare services.

(1) Cone beam CT provides three-dimensional anatomical images of patients, at isocenter immediately prior to being treated. Information on the location of bone is obtained from traditional orthogonal x-rays and the motion of tumors is captured by RGPT. These are then combined with the ability to identify healthy tissue surrounding a tumor, particularly the location and shape of soft tissue, via Cone beam CT.
(2) RGPT allows real-time beam irradiation to the tumor while compensating for movement associated with respiration. This technology was collaboratively developed between Hokkaido University and Hitachi, and supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) of the Japan Society for the Promotion of Science.

Overview of Particle Therapy

Particle Therapy is an advanced type of cancer radiotherapy. Protons extracted from hydrogen atoms, or carbon ions are accelerated up to 70% of the speed of light. This energy is concentrated directly on the tumor while minimizing radiation dose to surrounding healthy tissue. Particle therapy improves the quality of life for cancer patients since the patient experiences no pain during treatment and the procedure has very few side effects compared to that of traditional radiotherapy. In most cases, patients can continue with their normal daily activities while undergoing treatment.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, contributes to a sustainable society with a higher quality of life by driving innovation through data and technology as the Social Innovation Business. Hitachi is focused on strengthening its contribution to the Environment, the Resilience of business and social infrastructure as well as comprehensive programs to enhance Security & Safety. Hitachi resolves the issues faced by customers and society across six domains: IT, Energy, Mobility, Industry, Smart Life and Automotive Systems through its proprietary Lumada solutions. The company's consolidated revenues for fiscal year 2020 (ended March 31, 2021) totaled 8,729.1 billion yen ($78.6 billion), with 871 consolidated subsidiaries and approximately 350,000 employees worldwide. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.


Copyright 2022 JCN Newswire. All rights reserved. www.jcnnewswire.comHitachi, Ltd. has announced that "Shonan Kamakura Advanced Medical Center" at Shonan Kamakura General Hospital of Tokushukai Medical Group, where Hitachi's compact proton therapy system has been installed, has commenced treatment with the system on 31 January 2022.

Latest Intelligence

spot_img
spot_img
spot_img

Chat with us

Hi there! How can I help you?